Found: 59
Select item for more details and to access through your institution.
Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non--Small Cell Lung Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.912180
- By:
- Publication type:
- Article
Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 10, p. 676, doi. 10.3779/j.issn.1009-3419.2019.10.13
- By:
- Publication type:
- Article
Recommendation of Diagnosis and Management for the Infections Related to Immune Checkpoint Inhibitors.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 10, p. 666, doi. 10.3779/j.issn.1009-3419.2019.10.11
- By:
- Publication type:
- Article
Clinical Diagnosis and Treatment of Immune-related Adverse Events in Digestive System Related to Immune Checkpoint Inhibitors.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 10, p. 661, doi. 10.3779/j.issn.1009-3419.2019.10.10
- By:
- Publication type:
- Article
Clinical Diagnosis and Treatment Recommendations for Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 10, p. 627, doi. 10.3779/j.issn.1009-3419.2019.10.04
- By:
- Publication type:
- Article
Clinical Diagnosis and Treatment of Immune-related Adverse Events of Edocrine System Related to Immune Checkpoint Inhibitors.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 10, p. 649, doi. 10.3779/j.issn.1009-3419.2019.10.08
- By:
- Publication type:
- Article
Management of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 10, p. 671
- By:
- Publication type:
- Article
Clinical Diagnosis and Treatment Recommendation of Immune-related Adverse Renal Events Related to Immune Checkpoint Inhibitor.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 10, p. 645, doi. 10.3779/j.issn.1009-3419.2019.10.07
- By:
- Publication type:
- Article
Clinical Diagnosis and Treatment Recommendations for Ocular Toxicities of Target Therapy and Immune Checkpoint Inhibitor Therapy.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 10, p. 653, doi. 10.3779/j.issn.1009-3419.2019.10.09
- By:
- Publication type:
- Article
Clinical Diagnosis and Treatment Recommendations for the Pneumonitis Associated with Immune Checkpoint Inhibitor.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 10, p. 621, doi. 10.3779/j.issn.1009-3419.2019.10.03
- By:
- Publication type:
- Article
The Use of Glucocorticoid in the Management of Adverse Effects Related to Immunocheckpoint Inhibitors.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 10, p. 615, doi. 10.3779/j.issn.1009-3419.2019.10.02
- By:
- Publication type:
- Article
Management of Dermatologie Toxicities Related to Immune Checkpoint Inhibitors.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 10, p. 639, doi. 10.3779/j.issn.1009-3419.2019.10.06
- By:
- Publication type:
- Article
Diagnosis and Treatment Recommendation and Exploration for Critical and Refractory Adverse Effects Related to Immunocheckpoint Inhibitors.
- Published in:
- Chinese Journal of Lung Cancer, 2019, v. 22, n. 10, p. 605, doi. 10.3779/j.issn.1009-3419.2019.10.01
- By:
- Publication type:
- Article
Single-cell profiling identifies IL1B<sup>hi</sup> macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46195-x
- By:
- Publication type:
- Article
A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920965849
- By:
- Publication type:
- Article
Lactobacillus acidophilus Enhances Relief from Clinical Symptoms of Helicobacter pylori Infection in Patients on Quadruple Therapy.
- Published in:
- Current Topics in Nutraceutical Research, 2023, v. 21, n. 2, p. 125, doi. 10.37290/ctnr2641-452X.21:125-130
- By:
- Publication type:
- Article
Pulmonary and Skeletal Infection of .
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pulmonary and Skeletal Infection of Mycobacterium kansasii.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Assessment of CD27 expression on T-cells as a diagnostic and therapeutic tool for patients with smear-negative pulmonary tuberculosis.
- Published in:
- BMC Immunology, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s12865-021-00430-y
- By:
- Publication type:
- Article
Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03703-8
- By:
- Publication type:
- Article
Clinical characteristics and management of immune checkpoint inhibitor‐related pneumonitis: A single‐institution retrospective study.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 1, p. 188, doi. 10.1002/cam4.3600
- By:
- Publication type:
- Article
Analysis of cytokines in bronchoalveolar lavage fluid in patients with checkpoint inhibitor pneumonitis and pulmonary infection: A case–control study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 21, p. 2038, doi. 10.1111/1759-7714.14987
- By:
- Publication type:
- Article
Savolitinib versus crizotinib for treating MET positive non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 13, p. 1162, doi. 10.1111/1759-7714.14848
- By:
- Publication type:
- Article
The development of a tumor-associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor-based treatment in patients with advanced non-small-cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 5, p. 497, doi. 10.1111/1759-7714.14772
- By:
- Publication type:
- Article
Leptomeningeal enhancement in magnetic resonance imaging predicts poor prognosis in lung adenocarcinoma patients with leptomeningeal metastasis.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 7, p. 1059, doi. 10.1111/1759-7714.14362
- By:
- Publication type:
- Article
Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 539, doi. 10.1111/1759-7714.14289
- By:
- Publication type:
- Article
Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 3, p. 357, doi. 10.1111/1759-7714.13757
- By:
- Publication type:
- Article
Use of glucocorticoids in the management of immunotherapy‐related adverse effects.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 10, p. 3047, doi. 10.1111/1759-7714.13589
- By:
- Publication type:
- Article
Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 8, p. 2077, doi. 10.1111/1759-7714.13553
- By:
- Publication type:
- Article
Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum‐pemetrexed: The first report of two cases.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 8, p. 2339, doi. 10.1111/1759-7714.13520
- By:
- Publication type:
- Article
Treatment with or without bevacizumab as a first‐line and maintenance therapy for advanced non‐squamous non‐small cell lung cancer: A retrospective study.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 7, p. 1869, doi. 10.1111/1759-7714.13469
- By:
- Publication type:
- Article
Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non‐small cell lung cancer patients.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 6, p. 1647, doi. 10.1111/1759-7714.13447
- By:
- Publication type:
- Article
Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 6, p. 1621, doi. 10.1111/1759-7714.13442
- By:
- Publication type:
- Article
Opportunistic infections complicating immunotherapy for non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 6, p. 1689, doi. 10.1111/1759-7714.13422
- By:
- Publication type:
- Article
Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor‐induced renal immune‐related adverse events.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 6, p. 1746, doi. 10.1111/1759-7714.13405
- By:
- Publication type:
- Article
Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 5, p. 1216, doi. 10.1111/1759-7714.13376
- By:
- Publication type:
- Article
Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 4, p. 1099, doi. 10.1111/1759-7714.13347
- By:
- Publication type:
- Article
Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated adverse events in the digestive system.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 4, p. 829, doi. 10.1111/1759-7714.13338
- By:
- Publication type:
- Article
Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 3, p. 810, doi. 10.1111/1759-7714.13327
- By:
- Publication type:
- Article
Management of immune checkpoint inhibitor‐related adverse events: A review of case reports.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 3, p. 498, doi. 10.1111/1759-7714.13315
- By:
- Publication type:
- Article
Recommendation for the diagnosis and management of immune checkpoint inhibitor related infections.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 3, p. 805, doi. 10.1111/1759-7714.13313
- By:
- Publication type:
- Article
Histologic transformation of lung cancer during pembrolizumab therapy: A case report.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 3, p. 793, doi. 10.1111/1759-7714.13312
- By:
- Publication type:
- Article
Abivertinib in patients with T790M‐positive advanced NSCLC and its subsequent treatment with osimertinib.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 3, p. 594, doi. 10.1111/1759-7714.13302
- By:
- Publication type:
- Article
Management of immune checkpoint inhibitor‐related dermatologic adverse events.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 2, p. 488, doi. 10.1111/1759-7714.13275
- By:
- Publication type:
- Article
Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 3, p. 799, doi. 10.1111/1759-7714.13281
- By:
- Publication type:
- Article
Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 2, p. 475, doi. 10.1111/1759-7714.13250
- By:
- Publication type:
- Article
Management of immune checkpoint inhibitor‐related rheumatic adverse events.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 1, p. 198, doi. 10.1111/1759-7714.13249
- By:
- Publication type:
- Article
Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 1, p. 191, doi. 10.1111/1759-7714.13240
- By:
- Publication type:
- Article
EGFR T790M detection in formalin‐fixed paraffin‐embedded tissues of patients with lung cancer using RNA‐based in situ hybridization: A preliminary feasibility study.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 10, p. 1936, doi. 10.1111/1759-7714.13169
- By:
- Publication type:
- Article
Management of anlotinib‐related adverse events in patients with advanced non‐small cell lung cancer: Experiences in ALTER‐0303.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 3, p. 551, doi. 10.1111/1759-7714.12977
- By:
- Publication type:
- Article